Growing prevalence of cancer to augment generic oncology sterile injectable market growth

Market Overview:

Generic oncology sterile injectable are widely used for the treatment of cancers prostate, breast, colorectal, melanoma, lung, and bronchus. They have the same active ingredients as that of the branded version, with only the inactive contents of the drugs being different.

Competitive Landscape:

Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc.

Key Market Drivers:

Growing prevalence of chronic disease such as breast, prostate, colorectal, melanoma, lung, and bronchus is driving growth of the generic oncology sterile injectable market. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

Increasing partnership and collaboration in the field of generic oncology sterile injectable is again fostering market growth. For instance, in February 2017 – Baxter International Inc. and ScinoPharm Taiwan, Ltd. announced a strategic partnership to develop, manufacture and commercialize five injectable drugs used in a range of cancer treatments, including lung cancer, multiple myeloma and breast cancer, as well as medication to treat nausea and vomiting, common side effects of chemotherapy.

Covid-19 Impact Analysis

Spread of Covid-19 has impacted the supply and demand of generic oncology sterile injectable. This is attributed to the imposed of lockdown and quarantine policies to curb the spread of infection.

Key Takeaways:

1. The generic oncology sterile injectable market is expected to exhibit a CAGR of 11.5% over the forecast owing to the growing prevalence of cancer.

2. North America is expected to gain significant growth over the forecast period owing to the growing initiatives by key players to expand production of generic oncology sterile. For instance, in July 2019, Nexus has entered into an agreement with Wisconsin’s village Pleasant Prairie for the development of a sterile injectable manufacturing facility.

Comments

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin

Mixed Reality in Healthcare Market 2022 Global Industry Analysis By Size, Share, Trends and Growth Till 2028

Mixed Reality technologies help in improving the productivity of healthcare professionals. They are able to work more productively as they are allowed to fully enjoy all the benefits of both worlds. The main use of augmented reality or virtual reality in this regard is related to the treatment and rehabilitation of patients in a medical environment. There are many pharmaceutical companies that are using the technologies to manufacture better medicines and better equipment. Mixed Reality in Healthcare Market - Market Dynamics Growing demand for digitalization in healthcare sector is a major factor contributing to significant growth of mixed reality in healthcare market . Moreover, the market is expected to witness positive growth with rising prevalence of neurological & psychological disorders across the world.

Structural Heart Devices Market to develop innovative Mitral Valve Repair Technology

Structural heart devices Market are medical devices with the ability to pump blood by way of the heart. This device is called the ventricular myocardium, and it is what pumps blood from the heart to the various chambers of the body. The structure that this type of heart device has is very basic - a couple of stacks of cells (or more, depending upon the desired function), and a tubing filled with fluid that can allow for the movement of the cells. This particular construction has allowed these devices to be built so that they can pump blood and create heart attacks and heart failure with much greater efficiency. Lack of skilled personnel and low affordability is expected to restrain growth of the global structural heart devices market during the forecast period. However, the emergence of tissue-engineered heart valves and the advent of percutaneous interventions can offer major business opportunities in the global structural heart devicesmarket . Key players involved in the global

Healthcare News

Search This Blog